Royal Bank Of Canada Edwards Lifesciences Corp Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 1,971,713 shares of EW stock, worth $149 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,971,713
Previous 2,463,683 19.97%
Holding current value
$149 Million
Previous $228 Million 42.83%
% of portfolio
0.03%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$59.7 - $93.78 $29.4 Million - $46.1 Million
-491,970 Reduced 19.97%
1,971,713 $130 Million
Q2 2024

Nov 06, 2024
SELL
$84.3 - $94.31 $535,389 - $598,962
-6,351 Reduced 0.26%
2,463,683 $228 Million
Q2 2024

Aug 14, 2024
SELL
$84.3 - $94.31 $21.8 Million - $24.3 Million
-258,081 Reduced 9.46%
2,470,034 $228 Million
Q1 2024

Nov 05, 2024
BUY
$72.54 - $95.56 $18.2 Million - $24 Million
251,298 Added 10.17%
2,721,332 $260 Million
Q1 2024

May 15, 2024
BUY
$72.54 - $95.56 $4.79 Million - $6.31 Million
66,032 Added 2.48%
2,728,115 $261 Million
Q4 2023

Feb 14, 2024
SELL
$61.71 - $77.76 $82.4 Million - $104 Million
-1,334,940 Reduced 33.4%
2,662,083 $203 Million
Q3 2023

Nov 14, 2023
SELL
$69.28 - $93.38 $48.4 Million - $65.2 Million
-698,748 Reduced 14.88%
3,997,023 $277 Million
Q2 2023

Aug 14, 2023
BUY
$81.41 - $94.33 $18.5 Million - $21.4 Million
226,787 Added 5.07%
4,695,771 $443 Million
Q1 2023

May 15, 2023
SELL
$74.26 - $84.51 $25.9 Million - $29.4 Million
-348,205 Reduced 7.23%
4,468,984 $370 Million
Q4 2022

Feb 14, 2023
SELL
$68.3 - $87.44 $2.55 Million - $3.27 Million
-37,343 Reduced 0.77%
4,817,189 $359 Million
Q3 2022

Nov 14, 2022
SELL
$82.37 - $107.29 $35.7 Million - $46.6 Million
-434,004 Reduced 8.21%
4,854,532 $401 Million
Q2 2022

Aug 15, 2022
SELL
$86.5 - $128.27 $72.1 Million - $107 Million
-833,153 Reduced 13.61%
5,288,536 $503 Million
Q1 2022

May 16, 2022
SELL
$101.96 - $128.34 $38.7 Million - $48.7 Million
-379,528 Reduced 5.84%
6,121,689 $721 Million
Q4 2021

Feb 14, 2022
SELL
$106.37 - $130.68 $1.45 Million - $1.78 Million
-13,588 Reduced 0.21%
6,501,217 $842 Million
Q3 2021

Nov 15, 2021
SELL
$102.91 - $122.75 $839,745 - $1 Million
-8,160 Reduced 0.13%
6,514,805 $738 Million
Q2 2021

Aug 16, 2021
BUY
$83.84 - $104.76 $547 Million - $683 Million
6,522,965 New
6,522,965 $676 Million

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
457M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email